Summit Therapeutics Inc. (SMMT)

Summit Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	20,104	13,160	1,829	897	263	387
Market Cap Growth	389.83%	619.43%	103.94%	241.23%	-32.01%	-28.06%
Enterprise Value	19,749	12,705	1,737	779	184	366
Last Close Price	27.07	17.84	2.61	4.25	2.69	4.70
PS Ratio	-	-	-	1272.24	145.30	449.56
PB Ratio	58.30	33.85	23.54	7.08	3.16	4.87
P/TBV Ratio	58.71	34.02	24.13	7.18	3.71	5.87
EV/Sales Ratio	-	-	-	1105.42	101.96	425.47
Debt / Equity Ratio	0.02	0.02	1.37	4.10	0.03	0.01
Asset Turnover	-	-	-	0.00	0.02	0.01
Quick Ratio	10.36	9.90	9.17	9.15	3.47	3.85
Current Ratio	10.63	10.15	9.30	16.93	3.80	4.41
Return on Equity (ROE)	-123.93%	-94.89%	-601.85%	-75.05%	-108.89%	-66.57%
Return on Assets (ROA)	-52.50%	-41.30%	-12.79%	-10.23%	-49.91%	-32.91%
Return on Capital (ROIC)	-58.34%	-45.49%	-13.38%	-10.87%	-64.91%	-40.97%
Earnings Yield	-1.20%	-1.68%	-33.62%	-8.78%	-33.71%	-13.63%
FCF Yield	-0.86%	-1.08%	-4.20%	-4.71%	-27.73%	-12.55%
Buyback Yield / Dilution	-3.86%	-15.96%	-220.50%	-109.60%	-32.67%	-111.78%

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q